000			02076 a2200613 4500
005			20250515232058.0
264		0	_c20101208
008			201012s 0 0 eng d
022			_a1573-7217
024	7		_a10.1007/s10549-010-1030-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aWitzel, Isabell
245	0	0	_aMonitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. _h[electronic resource]
260			_bBreast cancer research and treatment _cSep 2010
300			_a437-45 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aBreast Neoplasms _xblood
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aGermany
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aOdds Ratio
650	0	4	_aReceptor, ErbB-2 _xantagonists & inhibitors
650	0	4	_aTime Factors
650	0	4	_aTrastuzumab
650	0	4	_aTreatment Outcome
700	1		_aLoibl, Sibylle
700	1		_avon Minckwitz, Gunter
700	1		_aMundhenke, Christoph
700	1		_aHuober, Jens
700	1		_aHanusch, Claus
700	1		_aHenschen, Stephan
700	1		_aHauschild, Maik
700	1		_aLantzsch, Tilmann
700	1		_aTesch, Hans
700	1		_aLatos, Kunibert
700	1		_aJust, Marianne
700	1		_aHilfrich, Jörn
700	1		_aBarinoff, Jana
700	1		_aEulenburg, Christine Zu
700	1		_aRoller, Marc
700	1		_aUntch, Michael
700	1		_aMüller, Volkmar
773	0		_tBreast cancer research and treatment _gvol. 123 _gno. 2 _gp. 437-45
856	4	0	_uhttps://doi.org/10.1007/s10549-010-1030-9 _zAvailable from publisher's website
999			_c19966279 _d19966279